- FiercePharma

Free Newsletter

About | View Sample | Privacy

Popular Topics

Biography for Maureen Martino

Maureen Martino is the managing editor of the FierceMarkets Life Sciences group and a contributor to FierceBiotech and FierceMedicalDevices. She is a graduate of Franklin & Marshall College in Lancaster, PA. Prior to joining FierceMarkets in 2005, she was an intern at Johnson & Johnson's business development unit and quality control and compliance group. Maureen is passionate about covering emerging live science companies, breakthrough technologies and biopharma M&A. She loves traveling, reading, cooking and is a classically-trained pianist. Maureen is based in the Philadelphia area, and can be reached at maureen@fiercemarkets.com. You can follow her at @FierceBiotech on Twitter and find her on LinkedIn.

Articles by Maureen Martino

Contact Maureen

Actavis to launch novel pain medication in the US
December 22, 2011
Repligen Completes Acquisition of Novozymes Biopharma Sweden AB
December 22, 2011
AAIPharma Services Appoints Vice President of Packaging Services
December 22, 2011
Ranbaxy Announces Consent Decree with U.S. Food and Drug Administration
December 21, 2011
Lonza to Expand Early Phase Manufacturing Capacity
December 20, 2011
GPhA Reveals the Accelerated Recovery Initiative: An Unprecedented Multi-Stakeholder Proposal to Address Drug Shortages
December 20, 2011
Novartis Holly Springs cell culture influenza vaccine manufacturing facility first to be declared pandemic ready by US governmen
December 15, 2011
First U.S. cell-based flu vaccine plant set for dedication
December 15, 2011
FDA approval of reformulated scheduled analgesic product using Grünenthal's INTACTM technology
December 13, 2011
Endo Announces FDA Approval of a New Formulation of Opana® ER Designed To Be Crush-Resistant
December 13, 2011
Benefits abound with recently patented system that reduces phosphorus in wastewater, engineering team finds
December 8, 2011
Samsung and Biogen Idec Announce Joint Venture to Develop, Manufacture and Market Biosimilars
December 8, 2011
Cegedim Strategic Data (CSD) Evaluates Physicians' Perception of Sales Representative Calls
December 5, 2011
BAUCUS, GRASSLEY, KOHL EXAMINE PHARMACEUTICAL DEALS THAT LIMIT ACCESS TO GENERIC DRUGS
December 1, 2011
RANBAXY ANNOUNCES LAUNCH OF ATORVASTATIN, GENERIC LIPITOR®, IN THE U.S.
December 1, 2011
FDA approves first generic version of cholesterol-lowering drug Lipitor
December 1, 2011
FDA Accepts ELIQUIS® (apixaban) New Drug Application for Review for the Prevention of Stroke and Systemic Embolism in Patients
November 29, 2011
Rib-X Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
November 28, 2011
PharMerica Responds to K-V Pharmaceutical's Statements Regarding Makena(R) and Compounded 17P
November 21, 2011
10 unusual biotech and pharma logos
November 21, 2011
Shire Announces Strategic Partnership for ADHD Medicines in Japan With Shionogi & Co., Ltd.
November 18, 2011
Eisai Enters into Japan Co-promotion Agreement with Novartis Pharma for COPD Therapies
November 18, 2011
Pfizer's Vyndaqel® (tafamidis) First Therapy Approved in the European Union for the Rare and Fatal Neurodegenerative Disease Tra
November 17, 2011
Pharmaceutical Commerce Finds Premier Report Inaccurate in Reporting Drug Price Profit Margins of Small Distributors
November 17, 2011
Metrics, Inc. Potent Facility Now Offers Neat API Capsule Filling
November 15, 2011

Paid Research Reports

More Research Reports >>